Get startedLog in
    Picture of Disruptive Pharma AB (publ) logo

    DPHA — Disruptive Pharma AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Guard Therapeutics To Discontinue Development Of RMC-035

    Picture of Disruptive Pharma AB (publ) logoDisruptive Pharma AB (publ)
    05/12/2025 07:40
    Dec 5 (Reuters) - Guard Therapeutics International AB (publ) GUARD.ST:

SAID ON THURSDAY GUARD THERAPEUTICS PROVIDES ASSESSMENT OF FULL POINTER STUDY RESULTS

STUDY DID NOT MEET ITS PRIMARY OR KEY SECONDARY EFFICACY ENDPOINTS

GIVEN OVERALL NEGATIVE OUTCOME OF STUDY, CO DECIDED TO DISCONTINUE ALL FURTHER DEVELOPMENT OF RMC-035

 Source text for Workspace: nMFN6Qr0Jt
 Further company coverage: GUARD.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Disruptive Pharma AB (publ)

    See all news